Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinoma
瘤内注射树突状细胞联合抗HER2疗法可诱导强烈的全身抗肿瘤免疫反应，并使HER2阳性乳腺癌完全消退。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2022-004841
Ramamoorthi, Ganesan; Kodumudi, Krithika; Snyder, Colin; Grover, Payal; Zhang, Hongtao; Greene, Mark I; Basu, Amrita; Gallen, Corey; Wiener, Doris; Costa, Ricardo L B; Han, Hyo S; Koski, Gary; Czerniecki, Brian J
肿瘤
HER2
肿瘤免疫
树突状细胞
乳腺癌
细胞生物学
树突状细胞
免疫/内分泌
